Science DailyNew tech for controlling genetic inheritance and genome engineeringScience DailyThe authors also provide experimental validation for using active genetics as an efficient means for targeted gene insertion, or "transgenesis," and … Continue reading
Phys.OrgActive genetics technology opens new horizonsPhys.Org"Technical advances enabled by active genetics represent an innovative toolkit to engineer organisms with novel features, thereby enabling a new era of advances in synthetic biology,&quo… Continue reading
HPCwire (blog)IARPA Ramps Up Molecular Information Storage ProgramHPCwire (blog)Multiple, diverse approaches are anticipated, which may utilize DNA, polypeptides, synthetic polymers, or other sequence-controlled polymer media. TA2 (Retrieval).Develop a… Continue reading
EurekAlert (press release)Scientists make it possible to rank the risk of resistance genesEurekAlert (press release)The researchers exploited synthetic biology to sample a large mechanistic diversity of resistance genes to investigate the impact of gen… Continue reading
Curetoday.com |
Body Mass Index Plays a Surprising Role in Immunotherapy’s Effectiveness
Curetoday.com “Obesity has been previously investigated for its role in cancer and promoting tumor growth, at least partially by inducing a chronic inflammatory state,” the authors wrote. “However, it’s unclear how this would play out in the era of immunotherapy … |
Curetoday.com |
Body Mass Index Plays a Surprising Role in Immunotherapy’s Effectiveness
Curetoday.com “Obesity has been previously investigated for its role in cancer and promoting tumor growth, at least partially by inducing a chronic inflammatory state,” the authors wrote. “However, it’s unclear how this would play out in the era of immunotherapy … |
|
Roche notches fresh win amid crowd of immunotherapy cocktails
Reuters ZURICH, Feb 6 (Reuters) – Roche’s Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker’s immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals … |